Transcat Stock: Performing Well But Currently Overvalued (NASDAQ:TRNS)


Empty science laboratory

Solskin

Transcat (NASDAQ:TRNS) offers laboratory instrument services worldwide. It works in two segments: Distribution and Service. TRNS recently announced its Q1 FY24 results. I will analyze its financial result in this report. Although its revenue has increased, I think the company is currently overvalued. Hence, I



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *